Literature DB >> 35433368

Residual pulmonary hypertension after pulmonary thromboendarterectomy: incidence, pathogenesis and therapeutic options.

Laurent Godinas1,2, Tom Verbelen3, Marion Delcroix1,2.   

Abstract

Entities:  

Year:  2022        PMID： 35433368      PMCID： PMC9012192          DOI： 10.21037/acs-2021-pte-11

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN： 2225-319X


× No keyword cloud information.
  12 in total

1.  Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy.

Authors:  Aleksander Araszkiewicz; Szymon Darocha; Arkadiusz Pietrasik; Radosław Pietura; Stanisław Jankiewicz; Marta Banaszkiewicz; Sylwia Sławek-Szmyt; Andrzej Biederman; Tatiana Mularek-Kubzdela; Maciej Lesiak; Adam Torbicki; Marcin Kurzyna
Journal:  Int J Cardiol       Date:  2018-10-25       Impact factor: 4.164

2.  Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.

Authors:  John E Cannon; Li Su; David G Kiely; Kathleen Page; Mark Toshner; Emilia Swietlik; Carmen Treacy; Anie Ponnaberanam; Robin Condliffe; Karen Sheares; Dolores Taboada; John Dunning; Steven Tsui; Choo Ng; Deepa Gopalan; Nicholas Screaton; Charlie Elliot; Simon Gibbs; Luke Howard; Paul Corris; James Lordan; Martin Johnson; Andrew Peacock; Robert MacKenzie-Ross; Benji Schreiber; Gerry Coghlan; Kostas Dimopoulos; Stephen J Wort; Sean Gaine; Shahin Moledina; David P Jenkins; Joanna Pepke-Zaba
Journal:  Circulation       Date:  2016-04-06       Impact factor: 29.690

3.  Additional percutaneous transluminal pulmonary angioplasty for residual or recurrent pulmonary hypertension after pulmonary endarterectomy.

Authors:  Nobuhiko Shimura; Masaharu Kataoka; Takumi Inami; Ryoji Yanagisawa; Haruhisa Ishiguro; Takashi Kawakami; Yoshiro Higuchi; Motomi Ando; Keiichi Fukuda; Hideaki Yoshino; Toru Satoh
Journal:  Int J Cardiol       Date:  2015-01-27       Impact factor: 4.164

Review 4.  ERS statement on chronic thromboembolic pulmonary hypertension.

Authors:  Marion Delcroix; Adam Torbicki; Deepa Gopalan; Olivier Sitbon; Frederikus A Klok; Irene Lang; David Jenkins; Nick H Kim; Marc Humbert; Xavier Jais; Anton Vonk Noordegraaf; Joanna Pepke-Zaba; Philippe Brénot; Peter Dorfmuller; Elie Fadel; Hossein-Ardeschir Ghofrani; Marius M Hoeper; Pavel Jansa; Michael Madani; Hiromi Matsubara; Takeshi Ogo; Ekkehard Grünig; Andrea D'Armini; Nazzareno Galie; Bernhard Meyer; Patrick Corkery; Gergely Meszaros; Eckhard Mayer; Gérald Simonneau
Journal:  Eur Respir J       Date:  2021-06-17       Impact factor: 16.671

5.  Efficacy and safety of balloon pulmonary angioplasty for residual pulmonary hypertension after pulmonary endarterectomy.

Authors:  Ryosuke Ito; Jun Yamashita; Yuichi Sasaki; Sayo Ikeda; Shun Suzuki; Naotaka Murata; Hitoshi Ogino; Taishiro Chikamori
Journal:  Int J Cardiol       Date:  2021-04-09       Impact factor: 4.164

6.  Residual pulmonary hypertension after pulmonary endarterectomy: A meta-analysis.

Authors:  Wan Chin Hsieh; Pavel Jansa; Wei Chun Huang; Matus Nižnanský; Mohamend Omara; Jaroslav Lindner
Journal:  J Thorac Cardiovasc Surg       Date:  2018-05-17       Impact factor: 5.209

7.  Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.

Authors:  Xavier Jaïs; Andrea M D'Armini; Pavel Jansa; Adam Torbicki; Marion Delcroix; Hossein A Ghofrani; Marius M Hoeper; Irene M Lang; Eckhard Mayer; Joanna Pepke-Zaba; Loïc Perchenet; Adele Morganti; Gérald Simonneau; Lewis J Rubin
Journal:  J Am Coll Cardiol       Date:  2008-12-16       Impact factor: 24.094

8.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; David Montani; David S Celermajer; Christopher P Denton; Michael A Gatzoulis; Michael Krowka; Paul G Williams; Rogerio Souza
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

9.  Chronic thromboembolic pulmonary hypertension.

Authors:  Nick H Kim; Marion Delcroix; Xavier Jais; Michael M Madani; Hiromi Matsubara; Eckhard Mayer; Takeshi Ogo; Victor F Tapson; Hossein-Ardeschir Ghofrani; David P Jenkins
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

10.  Serial right heart catheter assessment between balloon pulmonary angioplasty sessions identify procedural factors that influence response to treatment.

Authors:  Karsten P Hug; J Gerry Coghlan; John Cannon; Dolores Taboada; Mark Toshner; Karen Sheares; Alessandro Ruggiero; Nicholas Screaton; David Jenkins; Joanna Pepke-Zaba; Stephen P Hoole
Journal:  J Heart Lung Transplant       Date:  2021-07-01       Impact factor: 10.247
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.